IL142499A0 - Building units for synthesis of backbone cyclized peptide analogs - Google Patents
Building units for synthesis of backbone cyclized peptide analogsInfo
- Publication number
- IL142499A0 IL142499A0 IL14249901A IL14249901A IL142499A0 IL 142499 A0 IL142499 A0 IL 142499A0 IL 14249901 A IL14249901 A IL 14249901A IL 14249901 A IL14249901 A IL 14249901A IL 142499 A0 IL142499 A0 IL 142499A0
- Authority
- IL
- Israel
- Prior art keywords
- backbone
- pct
- alpha
- date dec
- building units
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14249901A IL142499A0 (en) | 1994-06-08 | 2001-04-06 | Building units for synthesis of backbone cyclized peptide analogs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL109943A IL109943A (en) | 1994-06-08 | 1994-06-08 | Conformationally constrained backbone cyclized peptide analogs |
IL14249901A IL142499A0 (en) | 1994-06-08 | 2001-04-06 | Building units for synthesis of backbone cyclized peptide analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142499A0 true IL142499A0 (en) | 2002-03-10 |
Family
ID=11066224
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL109943A IL109943A (en) | 1994-06-08 | 1994-06-08 | Conformationally constrained backbone cyclized peptide analogs |
IL14249901A IL142499A0 (en) | 1994-06-08 | 2001-04-06 | Building units for synthesis of backbone cyclized peptide analogs |
IL14855302A IL148553A0 (en) | 1994-06-08 | 2002-03-07 | Backbone cyclized peptide analogs comprising more than one cyclization |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL109943A IL109943A (en) | 1994-06-08 | 1994-06-08 | Conformationally constrained backbone cyclized peptide analogs |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14855302A IL148553A0 (en) | 1994-06-08 | 2002-03-07 | Backbone cyclized peptide analogs comprising more than one cyclization |
Country Status (9)
Country | Link |
---|---|
US (4) | US5811392A (xx) |
EP (1) | EP0804468B1 (xx) |
JP (2) | JPH10504802A (xx) |
AT (1) | ATE360639T1 (xx) |
AU (1) | AU702362B2 (xx) |
CA (1) | CA2192305A1 (xx) |
DE (1) | DE69535483D1 (xx) |
IL (3) | IL109943A (xx) |
WO (2) | WO2004074316A1 (xx) |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117974A (en) * | 1991-10-02 | 2000-09-12 | Peptor Limited | Libraries of backbone-cyclized peptidomimetics |
US6407059B1 (en) * | 1994-06-08 | 2002-06-18 | Peptor Limited | Conformationally constrained backbone cyclized peptide analogs |
IL109943A (en) * | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
US5770687A (en) * | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
US6841533B1 (en) | 1995-12-07 | 2005-01-11 | Peptor Limited | Conformationally constrained backbone cyclized interleukin-6 antagonists |
US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
US6576239B1 (en) * | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
WO1999031121A2 (en) * | 1997-12-15 | 1999-06-24 | Peptor Ltd. | Branched building units for synthesizing cyclic peptides |
US6463334B1 (en) | 1998-11-02 | 2002-10-08 | Cardiac Pacemakers, Inc. | Extendable and retractable lead |
US6743772B1 (en) | 1998-11-24 | 2004-06-01 | Kristina Broliden | Use of parovirus capsid particles in the inhibition of cell proliferation and migration |
US6818612B2 (en) | 1998-11-24 | 2004-11-16 | Kristina Broliden | Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
NZ512088A (en) | 1998-12-08 | 2004-01-30 | Children S Hospital And Region | Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
US6343257B1 (en) | 1999-04-23 | 2002-01-29 | Peptor Ltd. | Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library |
US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
ATE509912T1 (de) * | 1999-06-14 | 2011-06-15 | Wisconsin Alumni Res Found | Oligomere und polymere von zyklischen imino- carbonsäuren |
WO2001036006A1 (en) * | 1999-11-19 | 2001-05-25 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
MXPA02010375A (es) * | 2000-04-19 | 2003-04-25 | Schering Corp | Inhibidores macrociclicos de la ns3-serina proteasa del virus de la hepatitis c que comprenden porciones alquil y arilalanina p2. |
US7056321B2 (en) | 2000-08-01 | 2006-06-06 | Endius, Incorporated | Method of securing vertebrae |
IL140233A0 (en) * | 2000-12-11 | 2002-02-10 | Peptor Ltd | Backbone cyclized analogs of heat shock proteins |
US7279304B2 (en) * | 2000-12-18 | 2007-10-09 | President And Fellows Of Harvard College | Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby |
US7189856B2 (en) * | 2001-12-28 | 2007-03-13 | Gideon Shapiro | Non-peptide somatostatin receptor ligands |
US20030144260A1 (en) * | 2002-01-03 | 2003-07-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Heterocyclic compounds, method of developing new drug leads and combinatorial libraries used in such method |
WO2003059933A2 (en) * | 2002-01-03 | 2003-07-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Conformationally constrained c-backbone cyclic peptides |
IL148921A0 (en) * | 2002-03-26 | 2002-09-12 | Peptor Ltd | Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy |
US6861236B2 (en) * | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
IL150384A0 (en) * | 2002-06-24 | 2002-12-01 | Peptor Ltd | Radiolabelled somatostatin analogs backbone cyclized through metal complexation |
US20040121407A1 (en) * | 2002-09-06 | 2004-06-24 | Elixir Pharmaceuticals, Inc. | Regulation of the growth hormone/IGF-1 axis |
DE602004018782D1 (de) | 2003-07-31 | 2009-02-12 | Tranzyme Pharma Inc | Räumlich definierte makrocyclen, die peptidbindungssurrogate enthalten |
CN1906209A (zh) | 2003-11-05 | 2007-01-31 | 达纳-法伯癌症研究所股份有限公司 | 稳定的α螺旋肽及其用途 |
US8648045B2 (en) | 2005-03-10 | 2014-02-11 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | VDAC1 compositions and methods of use thereof for regulating apoptosis |
WO2006095347A2 (en) | 2005-03-10 | 2006-09-14 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS |
US20060211507A1 (en) * | 2005-03-21 | 2006-09-21 | Intertex, Inc. | Stake for securing inflatable devices |
WO2006116565A2 (en) * | 2005-04-25 | 2006-11-02 | Amgen Inc. | Biodegradable peptide sustained release compositions containing porogens |
AU2006253733A1 (en) * | 2005-05-31 | 2006-12-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Backbone cyclized melanocortin stimulating hormone (alpha S ) analogs |
WO2006137075A1 (en) * | 2005-06-23 | 2006-12-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions and methods for preventing or treating hiv infection |
DE602006015985D1 (de) | 2005-09-30 | 2010-09-16 | Philadelphia Health & Educatio | Antigene gegen das leberstadium von plasmodium |
US8816050B2 (en) * | 2006-03-22 | 2014-08-26 | The Scripps Research Institute | Method of preparing glycopeptides |
CN104063056B (zh) * | 2006-04-06 | 2018-04-20 | 意美森公司 | 用于增强的触觉效果的系统和方法 |
WO2007113837A2 (en) | 2006-04-06 | 2007-10-11 | Ben-Gurion University Of The Negev | N-terminal vdac variants and uses thereof |
US8106013B2 (en) | 2006-05-19 | 2012-01-31 | Georgia Tech Research Corporation | ABC transporter ligand GATX1 |
US7403325B2 (en) * | 2006-05-19 | 2008-07-22 | Xerox Corporation | Electrophoretic display device |
EP2049138A4 (en) * | 2006-07-14 | 2011-11-09 | Georgia Tech Res Inst | CLC KANALLIGAND |
WO2008053486A1 (en) * | 2006-11-02 | 2008-05-08 | Sylvie Luria | Methods for screening for therapeutic molecules and use of the molecules therefrom |
DK2118123T3 (en) | 2007-01-31 | 2016-01-25 | Dana Farber Cancer Inst Inc | Stabilized p53 peptides and uses thereof |
ES2610531T3 (es) | 2007-03-28 | 2017-04-28 | President And Fellows Of Harvard College | Polipéptidos cosidos |
US8383589B2 (en) * | 2007-07-09 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Aegyptin and uses thereof |
WO2009094636A2 (en) * | 2008-01-25 | 2009-07-30 | The University Of North Carolina At Chapel Hill | Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
US20090275519A1 (en) * | 2008-02-08 | 2009-11-05 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
US20110144303A1 (en) * | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
EP2310407A4 (en) * | 2008-04-08 | 2011-09-14 | Aileron Therapeutics Inc | BIOLOGIC EFFECTIVE PEPTIDOMIMETIC MACROCYCLES |
EP2356139A4 (en) | 2008-07-23 | 2013-01-09 | Harvard College | LIGATURE OF STAPLED POLYPEPTIDES |
CA2737921C (en) | 2008-09-22 | 2019-01-15 | Aileron Therapeutics, Inc. | Methods for preparing purified alpha-helical peptidomimetic macrocycle compositions with low metal ppm levels |
EP2334318B1 (en) | 2008-10-06 | 2016-02-10 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding |
CA2744088A1 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
WO2010137012A1 (en) | 2009-05-25 | 2010-12-02 | Ramot At Tel-Aviv University Ltd. | Peptide therapy for amphiregulin mediated diseases |
EP2453908B1 (en) | 2009-07-13 | 2018-03-14 | President and Fellows of Harvard College | Bifunctional stapled polypeptides and uses thereof |
US20120270774A1 (en) | 2009-08-28 | 2012-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection |
US20110065645A1 (en) * | 2009-09-10 | 2011-03-17 | The Regents Of The University Of California | Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance |
US20130072439A1 (en) | 2009-09-22 | 2013-03-21 | Huw M. Nash | Peptidomimetic macrocycles |
ES2711526T3 (es) | 2010-08-13 | 2019-05-06 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
EP2665742B1 (en) | 2011-01-20 | 2016-04-20 | Oneday - Biotech And Pharma Ltd. | Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
DK2684888T3 (da) * | 2011-03-09 | 2019-08-19 | Jitsubo Co Ltd | Nye tværbundne peptider indeholdende ikke-peptid-tværbundet struktur, fremgangsmåde til syntetisering af tværbundne peptider og ny organisk forbindelse anvendt i fremgangsmåden |
US9487562B2 (en) | 2011-06-17 | 2016-11-08 | President And Fellows Of Harvard College | Stabilized polypeptides as regulators of RAB GTPase function |
RU2639523C2 (ru) | 2011-10-18 | 2017-12-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы и их применение |
WO2013111129A1 (en) | 2012-01-23 | 2013-08-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Stabilized peptide helices for inhibiting dimerization of chemokine c motif receptor 2 (ccr2) |
MX362492B (es) | 2012-02-15 | 2019-01-21 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos. |
JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス,インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
WO2014016831A1 (en) | 2012-07-23 | 2014-01-30 | Oneday - Biotech And Pharma Ltd. | Glutathione-elevating compositions and uses thereof |
EP2877194A4 (en) | 2012-07-25 | 2016-03-16 | Oneday Biotech And Pharma Ltd | Compositions and methods for increasing carnitine concentration in muscle tissue |
WO2014052647A2 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Proline-locked stapled peptides and uses thereof |
AU2013337388B2 (en) | 2012-11-01 | 2018-08-02 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
US10081654B2 (en) | 2013-03-13 | 2018-09-25 | President And Fellows Of Harvard College | Stapled and stitched polypeptides and uses thereof |
JPWO2014148489A1 (ja) * | 2013-03-19 | 2017-02-16 | 株式会社エム・エム・ティー | 環状ペプチド |
KR20160019547A (ko) | 2013-06-14 | 2016-02-19 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 안정화된 폴리펩티드 인슐린 수용체 조절제 |
EP3024844B1 (en) | 2013-07-25 | 2018-09-12 | The National Institute for Biotechnology in the Negev Ltd. | Short peptides derived from vdac1, compositions and methods of use thereof |
WO2015087334A1 (en) | 2013-12-15 | 2015-06-18 | Yissum Research Develoment Company Of The Hebrew University Of Jerusalem Ltd. | Viperistatin-derived peptides and uses thereof |
US9873724B2 (en) | 2013-12-20 | 2018-01-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Pro-angiogenic peptides and peptide conjugates |
CN106573032B (zh) | 2014-05-21 | 2022-03-18 | 哈佛大学的校长及成员们 | Ras抑制肽和其用途 |
SG11201702175YA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
KR20170058424A (ko) | 2014-09-24 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
WO2016125172A1 (en) | 2015-02-08 | 2016-08-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Peptides for the treatment of malignant proliferative diseases |
EP3294318A4 (en) | 2015-03-20 | 2019-04-03 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF |
US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP2018528217A (ja) | 2015-09-10 | 2018-09-27 | エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. | Mcl−1のモジュレーターとしてのペプチド模倣大環状分子 |
EP3464325A1 (en) | 2016-06-07 | 2019-04-10 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (myd88) |
EP3684794A1 (en) | 2017-09-19 | 2020-07-29 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Somatostatin prodrugs |
US11091522B2 (en) | 2018-07-23 | 2021-08-17 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
WO2020170249A1 (en) | 2019-02-21 | 2020-08-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Par4 derived peptides, analogs and uses thereof |
US20220213138A1 (en) | 2019-04-04 | 2022-07-07 | University Of Hong Kong | Cyclic compounds and methods of making and using |
WO2020230122A1 (en) | 2019-05-13 | 2020-11-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Peptides for the treatment of cancer |
JPWO2020230780A1 (xx) * | 2019-05-14 | 2020-11-19 | ||
US20230174582A1 (en) * | 2020-03-30 | 2023-06-08 | Ichimaru Pharcos Co., Ltd | Vipr2 antagonist peptide |
WO2022003673A1 (en) | 2020-06-30 | 2022-01-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Humanin analogs and uses thereof |
JPWO2023136342A1 (xx) * | 2022-01-17 | 2023-07-20 | ||
CN116003453B (zh) * | 2022-12-16 | 2024-07-30 | 江西中医药大学 | 一种基于双1,4-消除反应的可逆环化肽及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4011182A (en) * | 1975-03-21 | 1977-03-08 | American Home Products Corporation | Cyclic undecapeptide analogs of somatostatin and intermediates |
US3988304A (en) * | 1975-08-25 | 1976-10-26 | American Home Products Corporation | Cyclic dodecapeptide derivatives of somatostatin and intermediates thereof |
US4054558A (en) * | 1976-05-24 | 1977-10-18 | American Home Products Corporation | Cyclic dodecapeptide and intermediates therefor |
SU798098A1 (ru) * | 1977-12-14 | 1981-01-23 | Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp | Циклический аналог брадикинина,обла-дАющий СпОСОбНОСТью СОздАВАТь пРОлОНги-РОВАННый дЕпРЕССОРНый эффЕКТ B эКСпЕРиМЕН-TE ,A ТАКжЕ ВАСКул РНую пРОНи-цАЕМОСТь B эКСпЕРиМЕНТЕ |
US4191754A (en) * | 1979-02-28 | 1980-03-04 | Merck & Co., Inc. | Bicyclic somatostatin analogs |
US4235886A (en) * | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4310518A (en) * | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4923963A (en) * | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
EP0334244A3 (en) * | 1988-03-25 | 1991-05-29 | The Procter & Gamble Company | Bradykinin antagonist peptides |
JPH03504496A (ja) * | 1988-04-08 | 1991-10-03 | スクリプス クリニック アンド リサーチ ファウンデーション | 水素結合の共有結合置換により安定化されたポリペプチド |
IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
DE4119544C1 (xx) * | 1991-06-13 | 1992-10-15 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig, De | |
US5364851A (en) * | 1991-06-14 | 1994-11-15 | International Synthecon, Llc | Conformationally restricted biologically active peptides, methods for their production and uses thereof |
IL99628A (en) * | 1991-10-02 | 2004-07-25 | Yissum Res Dev Co | Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them |
US5371070A (en) * | 1992-11-09 | 1994-12-06 | The Salk Institute For Biological Studies | Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins |
US6194544B1 (en) * | 1993-07-09 | 2001-02-27 | Smithkline Beecham Corporation | Cyclic semi-random peptide libraries |
IL109943A (en) * | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
US5770687A (en) * | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
-
1994
- 1994-06-08 IL IL109943A patent/IL109943A/en not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/488,159 patent/US5811392A/en not_active Expired - Lifetime
- 1995-06-07 WO PCT/IB1995/000453 patent/WO2004074316A1/en active Search and Examination
- 1995-06-07 US US08/750,331 patent/US5883293A/en not_active Expired - Fee Related
- 1995-06-08 US US08/750,328 patent/US5874529A/en not_active Expired - Fee Related
- 1995-06-08 DE DE69535483T patent/DE69535483D1/de not_active Expired - Lifetime
- 1995-06-08 WO PCT/IB1995/000455 patent/WO1995033765A1/en active IP Right Grant
- 1995-06-08 AT AT95919592T patent/ATE360639T1/de not_active IP Right Cessation
- 1995-06-08 AU AU25365/95A patent/AU702362B2/en not_active Ceased
- 1995-06-08 EP EP95919592A patent/EP0804468B1/en not_active Expired - Lifetime
- 1995-06-08 JP JP8500618A patent/JPH10504802A/ja active Pending
- 1995-06-08 CA CA002192305A patent/CA2192305A1/en not_active Abandoned
-
1998
- 1998-07-22 US US09/120,237 patent/US6265375B1/en not_active Expired - Fee Related
-
2001
- 2001-04-06 IL IL14249901A patent/IL142499A0/xx active IP Right Grant
-
2002
- 2002-03-07 IL IL14855302A patent/IL148553A0/xx active IP Right Grant
-
2005
- 2005-09-14 JP JP2005267462A patent/JP2006077017A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2536595A (en) | 1996-01-04 |
US6265375B1 (en) | 2001-07-24 |
DE69535483D1 (de) | 2007-06-06 |
AU702362B2 (en) | 1999-02-18 |
US5811392A (en) | 1998-09-22 |
IL109943A (en) | 2006-08-01 |
JPH10504802A (ja) | 1998-05-12 |
JP2006077017A (ja) | 2006-03-23 |
WO1995033765A1 (en) | 1995-12-14 |
EP0804468B1 (en) | 2007-04-25 |
US5883293A (en) | 1999-03-16 |
WO2004074316A1 (en) | 2004-09-02 |
IL148553A0 (en) | 2002-09-12 |
EP0804468A1 (en) | 1997-11-05 |
US5874529A (en) | 1999-02-23 |
CA2192305A1 (en) | 1995-12-14 |
ATE360639T1 (de) | 2007-05-15 |
IL109943A0 (en) | 1994-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142499A0 (en) | Building units for synthesis of backbone cyclized peptide analogs | |
WO1997009344A3 (en) | Librairies of backbone-cyclized peptidomimetics | |
ES8800958A1 (es) | Un procedimiento para preparar nuevos dipeptidos con actividad inhibidora de renina. | |
HK1044527A1 (zh) | 對位取代的苯乙烯衍生物和其作為整合素劑的用途 | |
DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
ATE203515T1 (de) | Meta-substituierte phenylsulphonamidderivate | |
MX9801716A (es) | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. | |
TR199801594A2 (xx) | CCR-3 resept�r antagonistleri. | |
BG104138A (en) | 2-aminopyridines containing substituents with condensed rings as nos inhibitors | |
BE1002212A5 (fr) | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments. | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
CA2272990A1 (en) | Heptapeptide oxytocin analogues | |
NZ329807A (en) | NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome | |
WO2003059933A3 (en) | Conformationally constrained c-backbone cyclic peptides | |
MX9707683A (es) | Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. | |
LV10108A (lv) | Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni | |
MY120033A (en) | 1,2,3,4- tetrahydro- benzofuro[3,2-c] pyridine derivatives | |
NO995481L (no) | Glykokonjugater av 20 (S)-camptothecin | |
MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. | |
IT1277391B1 (it) | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita | |
MY105110A (en) | Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same | |
DK0989994T3 (da) | Streptograminderivater, deres fremstilling og præparater, der indeholder dem | |
EP0292923A3 (en) | Piperidine compounds and pharmaceutical uses thereof | |
MY118678A (en) | Phenylethanolaminotetralincarboxamide derivatives | |
TW340849B (en) | Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |